These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17570199)

  • 1. Interim results presented at EASL from PROVE 1 clinical trial of investigational drug telaprevir in patients with genotype 1 hepatitis C.
    Lang L
    Gastroenterology; 2007 Jun; 132(7):2283-4. PubMed ID: 17570199
    [No Abstract]   [Full Text] [Related]  

  • 2. PROVE data released on telaprevir.
    AIDS Patient Care STDS; 2007 May; 21(5):369. PubMed ID: 17518530
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of genotype one hepatitis C virus (HCV) infection in HIV co-infected patients using telaprevir based regimen.
    Siraj DS; Kabchi B; Ashraf MS; Shah K; Elnabtity M
    Braz J Infect Dis; 2015; 19(2):226-7. PubMed ID: 25528578
    [No Abstract]   [Full Text] [Related]  

  • 4. Excitement grows for potential revolution in hepatitis C virus treatment.
    Opar A
    Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermatological adverse effects during genotype-1 hepatitis C treatment with the protease inhibitors telaprevir and boceprevir. Patient management.
    Picard O; Cacoub P
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):437-40. PubMed ID: 22483956
    [No Abstract]   [Full Text] [Related]  

  • 6. HCV RNA viral load assessments in the era of direct-acting antivirals.
    Cobb B; Pockros PJ; Vilchez RA; Vierling JM
    Am J Gastroenterol; 2013 Apr; 108(4):471-5. PubMed ID: 23552304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telaprevir: hope on the horizon, getting closer.
    Weisberg IS; Jacobson IM
    Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 3 study results released for telaprevir and HCV.
    AIDS Patient Care STDS; 2010 Oct; 24(10):685-6. PubMed ID: 20945535
    [No Abstract]   [Full Text] [Related]  

  • 9. Protease inhibitors for treatment of genotype 1 hepatitis C virus infection.
    Rowe IA; Mutimer DJ
    BMJ; 2011 Nov; 343():d6972. PubMed ID: 22074942
    [No Abstract]   [Full Text] [Related]  

  • 10. Telaprevir-induced DRESS.
    Kesar V; Kesar V; Khaitova V; Motamed D; Schiano T
    J Drugs Dermatol; 2014 Feb; 13(2):199-200. PubMed ID: 24509972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C.
    Smith LS; Nelson M; Naik S; Woten J
    Ann Pharmacother; 2011 May; 45(5):639-48. PubMed ID: 21558488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
    Manns M
    MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hepatitis C 2010: a focus on protease inhibitors.
    Lemon M
    S D Med; 2010 Jun; 63(6):214-5. PubMed ID: 20853592
    [No Abstract]   [Full Text] [Related]  

  • 14. The management of hepatitis C.
    Pan JJ; Firpi RJ
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):23-35. PubMed ID: 19212305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New times for the treatment of chronic hepatitis C].
    Gerstoft J; Fomsgaard A
    Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial investigates two experimental HCV drugs.
    AIDS Patient Care STDS; 2010 Apr; 24(4):270. PubMed ID: 20402017
    [No Abstract]   [Full Text] [Related]  

  • 17. Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis.
    de Kanter CT; den Hollander JG; Verweij-van Wissen CP; Burger DM
    J Clin Virol; 2014 Aug; 60(4):431-2. PubMed ID: 24929751
    [No Abstract]   [Full Text] [Related]  

  • 18. Study Results Support Telaprevir-Based Therapy for HCV.
    AIDS Patient Care STDS; 2010 Nov; 24(11):746. PubMed ID: 21108519
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects.
    Bartels DJ; Zhou Y; Zhang EZ; Marcial M; Byrn RA; Pfeiffer T; Tigges AM; Adiwijaya BS; Lin C; Kwong AD; Kieffer TL
    J Infect Dis; 2008 Sep; 198(6):800-7. PubMed ID: 18637752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus therapies.
    Smith RE
    Nat Rev Drug Discov; 2006 Sep; 5(9):715-6. PubMed ID: 17001802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.